140 related articles for article (PubMed ID: 27008827)
41. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.
Adelzadeh L; Jourabchi N; Wu JJ
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):846-52. PubMed ID: 25081573
[TBL] [Abstract][Full Text] [Related]
42. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
Siddiqui MA
Curr Opin Rheumatol; 2007 May; 19(3):308-13. PubMed ID: 17414961
[TBL] [Abstract][Full Text] [Related]
43. [Biologics in rheumatology].
Wagner U
Internist (Berl); 2019 Oct; 60(10):1036-1042. PubMed ID: 31485714
[TBL] [Abstract][Full Text] [Related]
44. Use of biologics for psoriasis in Central and Eastern European countries.
Rencz F; Kemény L; Gajdácsi JZ; Owczarek W; Arenberger P; Tiplica GS; Stanimirović A; Niewada M; Petrova G; Marinov LT; Kazandhieva J; Péntek M; Brodszky V; Gulácsi L
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2222-30. PubMed ID: 26370506
[TBL] [Abstract][Full Text] [Related]
45. Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
Iannone F; Ferraccioli G; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Gorla R; Bazzani C; Govoni M; Farina I; Gremese E; Carletto A; Giollo A; Galeazzi M; Foti R; Bianchino L; La Grasta L; Lapadula G
Clin Rheumatol; 2018 Feb; 37(2):315-321. PubMed ID: 28980085
[TBL] [Abstract][Full Text] [Related]
46. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
Bonafede M; Joseph GJ; Princic N; Harrison DJ
J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
[TBL] [Abstract][Full Text] [Related]
47. Biologics in dermatology beyond psoriasis.
Han G
Cutis; 2014 May; 93(5):E21-7. PubMed ID: 24897148
[TBL] [Abstract][Full Text] [Related]
48. When biologics should be used in systemic lupus erythematosus?
Gottenberg JE; Lorenzo N; Sordet C; Theulin A; Chatelus E; Sibilia J
Presse Med; 2014 Jun; 43(6 Pt 2):e181-5. PubMed ID: 24933678
[TBL] [Abstract][Full Text] [Related]
49. [Biologics therapy for systemic lupus erythematosus. Current situation].
Hoyer BF; Dörner T
Z Rheumatol; 2015 Apr; 74(3):206-14. PubMed ID: 25854155
[TBL] [Abstract][Full Text] [Related]
50. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
51. Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure.
Kusakari Y; Yamasaki K; Takahashi T; Tsuchiyama K; Shimada-Omori R; Nasu-Tamabuchi M; Aiba S
J Dermatol; 2015 Jul; 42(7):727-30. PubMed ID: 25916786
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
53. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Furie R; Toder K; Zapantis E
Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
[TBL] [Abstract][Full Text] [Related]
54. Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
Hagiwara S; Tsuboi H; Honda F; Takahashi H; Kurata I; Ohyama A; Yagishita M; Abe S; Kurashima Y; Kaneko S; Kawaguchi H; Takahashi H; Ebe H; Yokosawa M; Asashima H; Hirota T; Umeda N; Kondo Y; Matsumoto I; Sumida T
Mod Rheumatol; 2016 Nov; 26(6):857-862. PubMed ID: 26873159
[TBL] [Abstract][Full Text] [Related]
55. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
[TBL] [Abstract][Full Text] [Related]
56. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
González-Álvaro I; Martínez-Fernández C; Dorantes-Calderón B; García-Vicuña R; Hernández-Cruz B; Herrero-Ambrosio A; Ibarra-Barrueta O; Martín-Mola E; Monte-Boquet E; Morell-Baladrón A; Sanmartí R; Sanz-Sanz J; de Toro-Santos FJ; Vela P; Román Ivorra JA; Poveda-Andrés JL; Muñoz-Fernández S; ;
Rheumatology (Oxford); 2015 Jul; 54(7):1200-9. PubMed ID: 25526976
[TBL] [Abstract][Full Text] [Related]
57. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
[TBL] [Abstract][Full Text] [Related]
58. [Biologics in SLE].
Karonitsch T; Aringer M
Wien Med Wochenschr; 2015 Jan; 165(1-2):40-5. PubMed ID: 25411010
[TBL] [Abstract][Full Text] [Related]
59. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
60. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
Kim Y; Park S; Kim HS
Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
